Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran

British Journal of Haematology

Volumn 169, Issue 4, 2015, Pages 603-604

  Getta, Bartlomiej ^a   Muller, Niccolo ^a   Motum, Penelope ^a   Hsu, Danny ^a   Zebeljan, Diane ^a   Rosenfeld, David ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

Anticoagulants; Anticoagulation; Bleeding disorders

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; DABIGATRAN; FRESH FROZEN PLASMA; LACTIC ACID; VITAMIN K GROUP; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

AGED; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CASE REPORT; CEREBROVASCULAR ACCIDENT; CONTINUOUS HEMODIALYSIS; CRYOPRECIPITATE; DIALYSATE; DIALYSIS MEMBRANE; FILTER; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HEMODIALYSIS MACHINE; HUMAN; INGUINAL HERNIA; INTESTINE ISCHEMIA; KIDNEY DYSFUNCTION; LETTER; LIVER DYSFUNCTION; MALE; OLIGURIA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; THROMBIN TIME; VERY ELDERLY; VITAMIN K DEFICIENCY; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; HEMORRHAGE; RENAL REPLACEMENT THERAPY;

AGED, 80 AND OVER; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; HEMORRHAGE; HUMANS; MALE; RENAL DIALYSIS;

EID: 84928431917     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13236     Document Type: Letter

References (5)

1. Chang, D.N., Dager, W.E. & Chin, A.I. (2013) Removal of dabigatran by hemodialysis. American Journal of Kidney Diseases, 61, 487-489.
2. Lambourne, M.D., Eltringham-Smith, L.J., Gataiance, S., Arnold, D.M., Crowther, M.A. & Sheffield, W.P. (2012) Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. Journal of Thrombosis and Haemostasis, 10, 1830-1840.
3. Pragst, I., Zeitler, S.H., Doerr, B., Kaspereit, F.J., Herzog, E., Dickneite, G. & van Ryn, J. (2012) Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model. Journal of Thrombosis and Haemostasis, 10, 1841-1848.
4. Stangier, J., Rathgen, K., Stahle, H., Gansser, D. & Roth, W. (2007) The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. British Journal of Clinical Pharmacology, 64, 292-303.
5. Stangier, J., Rathgen, K., Stahle, H. & Mazur, D. (2010) Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clinical Pharmacokinetics, 49, 259-268.